Fig. 4From: The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysisThe pooled proportions for 30-day complications among recurrent ovarian cancer patients after secondary cytoreductive surgeryBack to article page